Alert: Hydroxycut Lawsuits Have Already Been Registered
On May one, 2009, there was a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that folks using the products were developing serious liver issues and other health issues. Less than a week later, on May four, the first Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Class Action Lawsuit alleges company laxity in informing the public about potential perils of the products. Naturally, it’s too shortly to know how the suit is going to turn out, but if the company had information which it didn’t divulge to consumers, it should definitely be held accountable.
A class action lawsuit is filed by a group of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less pricey, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there is a settlement. At that point, the lawyer who handled the suit will take his fees from the compensation that got given and then distribute the leftover funds to the accusers in the case. Since this is the case, you will be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action legal actions became so popular.
The first class action legal action against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health issues due to Hydroxycut products. The FDA recall took place in the United States where twenty-three cases of liver disorders and other health problems had been reported. Health Canada failed to receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning people who sustained respiration, neurological, cardiovascular, and gut problems as a result of Canadians using the products.
The Hydroxycut Liver Damage Suits alleges the company sold the products without correctly informing the general public of the public of the health risks that they could exposing patrons to. The complaint states that the company failed to publish the data on the product labels saying that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to allege that this was an obvious omission on the part of the company which deliberately misled clients concerning the protection of the products.
